COMP <GO>
HCAT vs SPCX // RETURN ON INVESTED CAPITAL (ROIC)
Health Catalyst Inc (NASDAQ) VS. Space Exploration Technologies Corp. (NASDAQ) • 15-METRIC TALLY: HCAT 1
— SPCX 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: SPCX
LAST: $1.69 (-5.59%) • MKT CAP: $134.7M
roic
-35.00%
LAST: $134.72 (-6.37%) • MKT CAP: $1.95T
roic
58.30%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HCAT VS. SPCX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HCAT | SPCX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 58.30% | -93.30 | SPCX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 14.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -0.18% | 3.99% | -4.17 | SPCX | /fcf-yield <GO> |
| Operating Margin | -51.70% | 21.10% | -72.80 | SPCX | /operating-margins <GO> |
| Net Profit Margin | -57.20% | 16.40% | -73.60 | SPCX | /net-margins <GO> |
| Revenue Growth (YoY) | 1.50% | 20.90% | -19.40 | SPCX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 26.00 | -25.80 | SPCX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | SPCX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.8 | 45.9 | +7.90 | HCAT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.36 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $134.7M | $1.95T | -$1.95T | SPCX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HCAT REV | SPCX REV | HCAT GROSS % | SPCX GROSS % | HCAT FCF | SPCX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $311.1M | $0 | — | — | -$237.0K | $0 |
| FY 2024 | $306.6M | — | — | — | $12.9M | — |
| FY 2023 | $295.9M | — | — | — | -$33.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HCAT // BETA —
SPCX // BETA 1.36